IONS logo

Ionis Pharmaceuticals Inc (IONS)

Ionis Pharmaceuticals, Inc., a commercial-stage biotechnology company, provides RNA-targeted medicines in the United States. The company offers TRYNGOLZA reduces triglyceride levels in adults with familial chylomicronemia syndrome (FCS) and acute pancreatitis; DAWNZERA for prophylaxis to prevent attacks of hereditary angioedema in adults; WAINUA for the trea...

NASDAQHealthcareBiotechnologyUSA

公司简介

股票代码
IONS
ISIN代码
US4622221004
货币
US Dollar (USD)
IPO日期
1991-05-17

联系信息

公司地址
2855 Gazelle Court, Carlsbad, CA, United States, 92010
联系电话
760 931 9200
公司网站
https://www.ionis.com
财年结束
December

财务亮点

市值
$999,999.99
毛利润(TTM)
$-999,999.99
资产回报率(TTM)
-12.43%
EBITDA
$-999,999.99
收入(TTM)
$999,999.99